Close
Smartlab Europe
Inizio Ignite

Press Releases

Emmes Supports New Collaboration to Accelerate COVID-19 Research for Children

Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical innovation, announced its role as a Data Coordinating Center on a team whose work has accelerated pediatric COVID-19 research through the Pharmacokinetics,...

Sensitech Launches App-Enabled, Touchless Temperature Monitoring Solution for Enhanced Supply Chain Visibility

Sensitech, a leading provider of global supply chain visibility solutions, launched the TempTale® Ultra BLE, the newest wireless addition to its industry-leading line of digital temperature monitoring solutions. Sensitech is part of Carrier Global Corporation, the leading global provider...

Oak Hill Bio Launches with Pipeline and Senior Leadership from Takeda

Oak Hill Bio, a clinical-stage rare disease therapeutics company developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases, announced the Company’s launch and plans to advance a pipeline of promising clinical and preclinical investigational...

Zydus supplies the first consignment of its COVID-19 vaccine ZyCoV-D

Zydus announced that the company has started the supplies of its COVID-19 vaccine ZyCoV-D, to the Government of India against their order from its newly commissioned state-of-the-art, Zydus Vaccine Technology Excellence Centre at the Zydus Biotech Park in Changodar,...

CAS, a division of the American Chemical Society launches major biology expansion

CAS, a division of the American Chemical Society specializing in scientific information solutions, announces the launch of a major expansion of the CAS SciFinder Discovery Platform into life sciences. The enhanced platform includes over 2 million modified biosequences, 60...

Novavax and Israel Announce Advance Purchase Agreement for Supply of COVID-19 Vaccine

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Israel's Ministry of Health today announced an agreement for the purchase of NVX-CoV2373, the company's recombinant nanoparticle protein-based COVID-19 vaccine candidate with...

European Commission Approves LORVIQUA as a First-Line Treatment for ALK-Positive Advanced Lung Cancer

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending to extend the approval of Dupixent® (dupilumab) in the European Union (EU) to include add-on maintenance treatment for children aged 6...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »